Evnin Luke has demonstrated a consistent and exclusive pattern of selling shares in Werewolf Therapeutics (HOWL), with no recorded purchases across 55 reported transactions totaling over $2.07 million in proceeds. The selling activity has been particularly concentrated in recent months, with 25 sales executed between December 9, 2025, and January 16, 2026. These transactions ranged from smaller dispositions like the $4,861 sale on January 8, 2026, to more substantial ones, including a $66,249 divestment on December 29, 2025, and a $45,015 sale on December 9, 2025.
The frequency of sales suggests an ongoing reduction in Luke’s position, with multiple transactions occurring in rapid succession—often on consecutive trading days. For example, between January 5 and January 16, 2026, Luke sold HOWL shares every business day except January 11, with daily proceeds fluctuating between $11,698 and $33,618. The absence of any buying activity, both in recent filings and across Luke’s entire transaction history, indicates a clear directional bias toward divestment rather than accumulation in this single holding. The consistency of these sales, without any offsetting purchases, underscores a sustained exit from the position rather than periodic rebalancing.
AI-assisted summary